menu
    • menu

    Company profile for NeuroStar

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We designed NeuroStar as a non-invasive therapeutic alternative to treat patients who suffer from major depressive disorder and to address many of the key limitations of existing treatment options. NeuroStar therapy provides our psychiatrist customers and their patients with several benefits, including11, 20 Clinically demonstrated response and remission with durable results A demonstrated safety profile with limited treatmen...
    We designed NeuroStar as a non-invasive therapeutic alternative to treat patients who suffer from major depressive disorder and to address many of the key limitations of existing treatment options. NeuroStar therapy provides our psychiatrist customers and their patients with several benefits, including11, 20 Clinically demonstrated response and remission with durable results A demonstrated safety profile with limited treatment-emergent side effects High patient adherence Additionally, our therapy was designed to provide a precise and reproducible office-based therapy that is also efficient and convenient.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NeuroStarUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3222 Phoenixville Pike Malvern, PA 19355
    Telephone
    Telephone
    1-877-600-7555
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://neurostar.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Natural Products Expo

    Natural Products Expo

    Not Confirmed

    envelop Contact Supplier

    Natural Products Expo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    NY Medicaid Expands TMS Therapy Coverage for MDD Patients
    NY Medicaid Expands TMS Therapy Coverage for MDD Patients

    17 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/17/3151639/0/en/New-York-State-Medicaid-Expands-Coverage-for-TMS-Therapy-Including-NeuroStar-Advanced-Therapy-to-Treat-Major-Depressive-Disorder-MDD.html

    GLOBENEWSWIRE
    17 Sep 2025
    Share Share
    NeuroStar Data in JAACAP Open Supports Depression Therapy
    NeuroStar Data in JAACAP Open Supports Depression Therapy

    30 Jul 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/07/30/3124076/0/en/NeuroStar-Announces-New-Publication-in-JAACAP-Open-Highlighting-Treatment-Efficacy-in-Depressed-Adolescents.html

    GLOBENEWSWIRE
    30 Jul 2025
    Share Share
    Neuronetics Reports Q4 and Full Year 2024 Financial Results
    Neuronetics Reports Q4 and Full Year 2024 Financial Results

    27 Mar 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/03/27/3051043/0/en/Neuronetics-Reports-Updated-Fourth-Quarter-and-Full-Year-2024-Financial-and-Operating-Results.html

    GLOBENEWSWIRE
    27 Mar 2025
    Share Share
    Neuronetics to Report Q4 2024 Financial and Operating Results
    Neuronetics to Report Q4 2024 Financial and Operating Results

    21 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/21/3030445/0/en/Neuronetics-to-Report-Fourth-Quarter-2024-Financial-and-Operating-Results-and-Host-Conference-Call.html

    GLOBENEWSWIRE
    21 Feb 2025
    Share Share
    Neuronetics Launches Underwritten Public Offering of Stock
    Neuronetics Launches Underwritten Public Offering of Stock

    06 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/06/3022468/0/en/Neuronetics-Announces-Launch-of-Underwritten-Public-Offering-of-Common-Stock.html

    GLOBENEWSWIRE
    06 Feb 2025
    Share Share
    NeuroStar Unveils 2 Significant Publications on TMS Therapy
    NeuroStar Unveils 2 Significant Publications on TMS Therapy

    29 Jan 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/01/29/3017200/0/en/NeuroStar-Unveils-Two-Significant-Publications-on-TMS-Therapy-for-Depression.html

    GLOBENEWSWIRE
    29 Jan 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search